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Abstract 
Background: Emergence of drug‑resistant Plasmodium falciparum has created an urgent need for new drug targets. 
DNA polymerase δ is an essential enzyme required for chromosomal DNA replication and repair, and therefore may 
be a potential target for anti‑malarial drug development. However, little is known of the characteristics and function 
of this P. falciparum enzyme.
Methods: The coding sequences of DNA polymerase δ catalytic subunit (PfPolδ‑cat), DNA polymerase δ small subu‑
nit (PfPolδS) and proliferating cell nuclear antigen (PfPCNA) from chloroquine‑ and pyrimethamine‑resistant P. falci-
parum strain K1 were amplified, cloned into an expression vector and expressed in Escherichia coli. The recombinant 
proteins were analysed by SDS‑PAGE and identified by LC–MS/MS. PfPolδ‑cat was biochemically characterized. The 
roles of PfPolδS and PfPCNA in PfPolδ‑cat function were investigated. In addition, inhibitory effects of 11 compounds 
were tested on PfPolδ‑cat activity and on in vitro parasite growth using SYBR Green I assay.
Results: The purified recombinant protein PfPolδ‑cat, PfPolδS and PfPCNA showed on SDS‑PAGE the expected 
size of 143, 57 and 34 kDa, respectively. Predicted amino acid sequence of the PfPolδ‑cat and PfPolδS had 59.2 and 
24.7 % similarity respectively to that of the human counterpart. The PfPolδ‑cat possessed both DNA polymerase and 
3′–5′ exonuclease activities. It used both Mg2+ and Mn2+ as cofactors and was inhibited by high KCl salt (>200 mM). 
PfPolδS stimulated PfPolδ‑cat activity threefolds and up to fourfolds when PfPCNA was included in the assay. Only 
two compounds were potent inhibitors of PfPolδ‑cat, namely, butylphenyl‑dGTP (BuPdGTP; IC50 of 38 µM) and 7‑ace‑
toxypentyl‑(3, 4 dichlorobenzyl) guanine (7‑acetoxypentyl‑DCBG; IC50 of 55 µM). The latter compound showed higher 
inhibition on parasite growth (IC50 of 4.1 µM).
Conclusions: Recombinant PfPolδ‑cat, PfPolδS and PfPCNA were successfully expressed and purified. PfPolS and 
PfPCNA increased DNA polymerase activity of PfPolδ‑cat. The high sensitivity of PfPolδ to BuPdGTP can be used to dif‑
ferentiate parasite enzyme from mammalian and human counterparts. Interestingly, 7‑acetoxypentyl‑DCBG showed 
inhibitory effects on both enzyme activity and parasite growth. Thus, 7‑acetoxypentyl‑DCBG is a potential candidate 
for future development of a new class of anti‑malarial agents targeting parasite replicative DNA polymerase.
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Background
Malaria remains one of the major global public health 
problems in more than 100 endemic countries. Even 
though the numbers of malaria cases are decreasing, in 
2013 there were still 198 million estimated cases globally 
and 584,000 deaths, mainly among sub-Saharan African 
children under 5  years of age [1]. Plasmodium falcipa-
rum is the most virulent human malaria parasite respon-
sible for the majority of mortality cases. The emergence 
of anti-malarial resistance, in particular to artemisinins, 
has become a problem in malarial treatment and con-
trol [2–4]. Therefore, a better understanding of parasite 
metabolism, leading to identification of enzymes essen-
tial for its survival, should help in finding new targets for 
drug development.
One of the chemotherapeutic targets of interest is 
malarial DNA polymerase, which is an enzyme directly 
involved in polymerization of deoxynucleotides dur-
ing replication and/or repair of cellular genetic material 
[5]. Eukaryotes possess 4 polymerases of the B-family, 
three of which, namely, DNA polymerase α (Pol α), DNA 
polymerase δ (Pol δ) and DNA polymerase ε (Pol ε), are 
essential enzymes for nuclear DNA replication [6]. Each 
enzyme plays a role in the replisome complex located 
at the replication fork, in which Pol δ replicates the lag-
ging strand after it has been primed by Pol α [7]. Both 
Pol δ and Pol ε are distinguished from Pol α by their 3′–5′ 
proof-reading exonuclease activity, which allows removal 
of mis-incorporated deoxynucleotides, ensuring a high 
fidelity of DNA synthesis required for accurate genome 
replication [6].
Pol δ holoenzyme participates in replicative synthesis 
in concert with the processivity factor proliferating cell 
nuclear antigen (PCNA). Kinetic and binding studies 
have shown that PCNA increases Pol δ processivity as 
well as activity [8], possibly by forming a trimeric closed 
ring structure, which encircles the DNA and provides a 
sliding clamp for attachment of Pol δ [9]. In addition to 
its function in DNA replication, Pol δ plays a role in DNA 
repair and recombination [6]. In base excision repair 
(BER), one of DNA repair mechanisms of single-stranded 
DNA damage, Pol δ is involved in the long-path pathway, 
whereas Pol β plays a role in the short-path pathway [10]. 
Interestingly, the long-patch BER is predominate in P. fal-
ciparum while short-path BER is mainly found in humans 
[11].
Pol δ has been purified from a number of eukaryotes. 
In Saccharomyces cerevisiae, Pol δ is composed of three 
subunits: catalytic subunit Pol3p and structural subu-
nits Pol31p and Pol32p [12–14]. In Schizosaccharomy-
ces pombe, Pol δ consists of four subunits: Pol3, Cdc 1, 
Cdc27 and Cdm1 [15]. Human and mammalian enzymes 
initially were characterized as a heterodimer of p125 
catalytic and p50 subunits [16, 17]. The p125 catalytic 
subunit is homologous to yeast Pol3 and Pol3p, whereas 
subunit p50 is a homologue of Cdc 1 and Pol31p [18, 19]. 
Later, two additional subunits of human and mammalian 
Pol δ were identified, namely, p68 and p12, displaying 
significant homology with Schizosaccharomyces pombe 
Cdc27 and Cdm1 respectively [20, 21]. Unlike mamma-
lian Pol δ holoenzyme, formed by four subunits [21], only 
two subunits (p125 catalytic subunit and p50 small subu-
nit) were identified in the Plasmodb sequence database.
Three types of P. falciparum DNA polymerases have 
been identified and characterized: nuclear Pol α and Pol 
β from parasite crude extract [22, 23] and Pol γ from 
parasite mitochondria [24]. Plasmodium falciparum (Pf )
Pol δ gene of 3282 bp is located on chromosome 10 and 
encodes a protein of 1094 amino acids with 45 % similar-
ity to Saccharomyces cerevisiae Pol δ [25, 26]. PfPol δ is 
expressed mainly in late trophozoite and schizont stages 
[27], but little is known about its enzymology and bio-
chemical characteristics.
This study describes the cloning and expression of 
PfPol δ catalytic subunit (PfPolδ-cat) and the charac-
terization of its activity in presence of its small subu-
nit (PfPolδS) and proliferating cell nuclear antigen 
(PfPCNA). In addition, the in  vitro inhibitory effects of 
11 synthetic compounds on both recombinant PfPolδ-cat 




Plasmodium falciparum strain K1, a chloroquine- and 
pyrimethamine-resistant strain from Thailand [28] was 
cultivated in RPMI 1640 medium (Invitrogen™, CA, 
USA) supplemented with 10 % human serum and human 
red blood cell (RBC) at 37 °C under an atmosphere of 5 % 
CO2. Plasmodium falciparum cultures containing mostly 
trophozoite and schizont stages were harvested when 
parasitaemia was >10  % by centrifugation at 500×g for 
10 min at 25 °C.
Construction of PfPolδ‑cat, PfPolδS and PfPCNA1 
expression vectors
Genomic DNA of P. falciparum strain K1 was used as 
template to generate full-length PfPolδ-cat, PfPolδS and 
PfPCNA1. Amplification of PfPolδ-cat was carried out 
using PfPolδ-cat-forward (5′-CACCCATGGAAGAACT 
GAAAAC-3′) and PfPolδ-cat-reverse (5′-CCAATCCATT 
CTTAATGAGGT-3′) primers and Phusion®High-Fidelity 
DNA polymerase (Thermo Scientific, MA, USA) together 
with 30 cycles of PCR consisting of 98 °C for 1 min, 63 °C 
for 10 s and 72 °C for 105 s. PfPolδS was amplified using 
PfPolδS-forward (5′-CACCATGGACGAAAAAGTAAC 
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AAAC-3′) and PfPolδ-p50-reverse (5′-TTTGTCTTCGTC 
AATTTGAAAAGTC-3′) primers and Platinum® Pfx 
DNA polymerase (Invitrogen™) together with 35 cycles 
of PCR consisting of 95 °C for 1 min, 56 °C for 40 s and 
72  °C for 2  min. Pf-PCNA1 was amplified using prim-
ers previously described [29] and Phusion®High-Fidelity 
DNA polymerase together with 35 cycles of PCR con-
sisting of 98  °C for 10  min, 58  °C for 5  s and 72  °C for 
30 s. Amplicons were analysed either by 0.8 or 1.5 % aga-
rose gel-electrophoresis. Amplified full-length PfPolδ-
cat and PfPolδS was cloned into pBAD202/D TOPO® 
and pET101/D TOPO® expression vector (Invitrogen™), 
respectively. The constructed vectors, pBAD-PfPolδ-cat 
and pET-PfPolδS, were validated by nucleotide sequenc-
ing. Amplified full-length Pf-PCNA1 was cloned into 
pQE-30 expression vector and named pQE-30-PfPCNA1.
Expression and purification of PfPolδ‑cat, PfPolδS 
and PfPCNA1
pBAD-PfPolδ-cat vector was transfected into E. coli 
LMG194 cells, which were grown in LB medium con-
taining 50  μg/ml kanamycin at 37  °C with shaking 
until optical density of 600 nm reached 0.8. Then cells 
were induced by an addition of 0.002  % (w/v) L-arab-
inose and further incubated at 22 °C for 16–18 h. Cells 
were sedimented at 4  °C and then re-suspended in 
3.5 volumes of cold lysis buffer (20  mM Tris–HCl pH 
8.0 and 100  mM NaCl) per g of bacterial pellet. Cells 
were lysed using XL 2020 Sonicator® Ultrasonic Pro-
cessor XL (Heat System Inc., NY, USA), centrifuged 
at 10,000×g for 30 min at 4  °C. Supernatant was incu-
bated with Q Sepharose Fast Flow (GE Healthcare, UK) 
on ice for 10  min to remove bacterial DNA and then 
applied onto 1-ml HisTrap HP column (GE Healthcare) 
prior equilibration with buffer A (20 mM Tris–HCl pH 
8.0, 300  mM NaCl) containing 10  mM imidazole. The 
column was washed with buffer A containing 50  mM 
imidazole and enzyme was eluted with 250 mM imida-
zole-containing buffer A. Protein purity was analysed 
by SDS-PAGE.
pET-PfPolδS vector was used to transform E. coli BL21 
(DE3) cells, which were grown in LB media contain-
ing 100  μg/ml ampicillin, and induced with 0.25  mM 
isopropyl β-D-1-thiogalactopyranoside (IPTG) at 22  °C 
for 16 h with shaking. Cells were collected and lysed as 
described previously. Supernatant was applied onto 1-ml 
HisTrap HP column and recombinant PfPolδS was eluted 
using a linear gradient of 20–250 mM imidazole in buffer 
A. Fractions of 0.25  ml were collected and analysed by 
SDS–PAGE.
pQE-30-PfPCNA1 was transfected into JM109 E. coli 
cells, which were grown in LB medium, induced with 
1  mM IPTG at 25  °C for 16  h, collected and lysed as 
described above. Supernatant was incubated with Ni–
NTA agarose affinity beads (QIAGEN, Hilden, Germany) 
at 4 °C for 2 h. The sample then was applied onto a grav-
ity column, washed and protein eluted. The flow-through, 
wash and eluted fractions were collected, and analysed by 
SDS-PAGE. Protein concentrations were measured using 
Bradford assay [30] with bovine serum albumin (BSA) as 
standard.
Western blotting and LC–MS/MS
After SDS-PAGE, proteins were electro-transferred 
onto Hybond-P PVDF membrane (GE Healthcare) 
and incubated at 4 °C overnight in phosphate-buffered 
saline (PBS) containing 5 % skim milk (blocking buffer). 
After washing three times with 0.05  % Tween-20 PBS 
buffer, membrane was incubated with mouse anti-His 
antibodies (Invitrogen) at 1:5000 dilution in block-
ing buffer at room temperature for 2 h. After washing, 
membrane was incubated with horseradish peroxidase-
conjugated goat anti-mouse IgG for 1.5 h at room tem-
perature and immunoreactive bands visualized using 
SuperSignal™ West Pico Chemiluminescent Substrate 
(Thermo Scientific). The expected protein bands were 
excised from gels and digested with trypsin. Patterns 
of peptide fragments and amino acid sequences were 
analysed using LC–MS/MS equipped with MASCOT 
software.
DNA polymerase assay
DNA polymerase activity was assayed using activated 
calf thymus DNA (CT-DNA) (Sigma-Aldrich, MA, 
USA) as substrate. DNA polymerase assay was con-
ducted in a 50-μl reaction mixture containing 10  μg 
of activated CT-DNA, 20  mM potassium phosphate 
buffer pH 8, 10  mM MgCl2, 2  mM DTT, 10  μg BSA, 
50  μM each of dGTP, dATP and dCTP, 1  μM dTTP, 
2.5 μM [α-32P]dTTP (800 Ci/mmol; PerkinElmer, MA, 
USA), and 42  nM PfPolδ-cat. After incubation for 1  h 
at 37  °C, the reactions were terminated by adding a 
250-μl mixture of 20  mM EDTA, 0.1  mg/ml BSA and 
100 μl of 50 % trichloroacetic acid (TCA), followed by 
sedimentation. The precipitate was then washed twice 
with 1 % TCA and [32P]dTMP incorporation was meas-
ured in a 1450 MicroBeta® Trilux Liquid Scintillation 
Counter (Perkin Elmer). One unit of DNA polymerase 
activity is defined as the amount of enzyme that cata-
lyzes the incorporation of 1  nmol of dTMP into DNA 
in 1 h at 37 °C.
Effects of divalent ions and KCl on PfPolδ‑cat activity
The effects of divalent cations, Mg2+ and Mn2+, on 
PfPolδ-cat activity were determined in the presence of 
0.3 μM PfPolδ-cat and 0–50 mM MgCl2 or MnCl2 in the 
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polymerase assay. The effect of KCl was determined over 
the range 0–400 mM.
3′–5′ exonuclease assay
The 3′–5′ exonuclease activity of PfPolδ-cat was meas-
ured from the release of [α-32P]dTMP from 3′ labelled 
poly(dA.dT) [16]. Substrate was prepared by incubating 
125 μg/ml poly(dA.dT) with 5000 U/ml Klenow enzyme 
(New England Biolabs, MA, USA), 10  μM [α-32P]dTTP 
in 50  mM potassium phosphate pH 7.5, 5  mM MgCl2, 
1  mM dAMP, and 0.5  mM β-mercaptoethanol. After 
incubation for 20 min at 37 °C, the reaction was termina-
tion by an addition of 10 mM EDTA and 1 M NaCl. The 
mixture was heated at 65 °C for 30 min and unincorpo-
rated [α-32P]dTTP removed employing AutoSeq™ G-50 
dye terminator removal kit (GE Healthcare). For detec-
tion of exonuclease activity, a 30-μl reaction mixture 
containing 50  mM HEPES pH 7.0, 40  μg/ml BSA, 10  % 
glycerol, 2 mM MgCl2, 1.25 µg of 3′-labelled poly(dA.dT), 
and 0.2 μM PfPolδ-cat was incubated for 20 min at 37 °C 
and radioactivity measured as described above.
Processivity assay
Processivity of PfPolδ-cat was determined using 500  ng 
of (dA)1500.(dT)12 (50:1 nucleotide ratio) as template-
primer. The dT12 primer was at 5′ labelled with [γ-32P]
dATP using T4 polynucleotide kinase and annealed to 
poly (dA)1500. Reaction mixture consisting of 20  mM 
Tris–HCl pH 9.0, 10 mM MgCl2, 0.2 mg/ml BSA, 2 mM 
DTT, 50 μM dTTP, and 42 nM PfPolδ-cat was incubated 
at 37  °C for 30  min. The product was precipitated with 
ethanol, dried, dissolved in sample buffer (95  % deion-
ized formamide, 25 mM EDTA and 0.01 % bromophenol) 
and electrophoresed in 8 % polyacrylamide gel contain-
ing 7 M urea. Gel was exposed overnight to X-ray film at 
−80 °C.
Effects of PfPolδS and PfPCNA1 on PfPolδ‑cat activity
PfPolδS (0–1  μM) was added to a standard DNA poly-
merase assay containing 0.15  μg of polydA.oligodT and 
1 μM PfPCNA1 and incubated at 37  °C for 30 min. The 
reaction mixtures were processed as described.
Inhibitory effects of synthetic compounds on PfPolδ‑cat 
activity
Inhibitory activity of 11 compounds consisting of sub-
strate and nucleotide analogs and potential active site 
occupiers of PfPolδ-cat were compared with known 
Pol δ inhibitors, aphidicolin and N-ethylmaleimide 
(NEM). Stock solution (6  mM) of aphidicolin was pre-
pared in dimethylsulfoxide (DMSO) and that of NEM 
(400  mM) in absolute ethanol. Stock solutions (10  mM) 
of N2-(4-butylphenyl)-2′-deoxyguanosine 5′-triphosphate 
(BuPdGTP), N2-(4-butylphenyl)- 2′-deoxyguanosine 
5′-(P2,P3-carbonyltriphosphonate) (BuPdGMPPCOP), N2-
ethyl-2′-deoxyguanosine 5′-triphosphonate (EtdGTP), N2-
hexyl-2′-deoxyguanosine 5′-triphosphate (HexdGTP) and 
Acyclovir triphosphate (ACV-TP) were prepared in sterile 
distilled water, while those of 2-amino-4-chloro-6-(3,4-
dichloroanilino)pyrimidine, 2-amino-4-chloro-6-(3,5-
dichloroanilino)pyrimidine, N2-(3,4-dichlorobenzyl)
guanine (DCBG), N2-(3-fluoro,4-chlorobenzyl)guanine, 
3-(4-hydroxybutyl)-6-(3-ethyl-4-methylanilino)uracil 
(HB-EMAU), and 7-acetoxypentyl-(3,4-dichlorobenzyl)
guanine (7-acetoxypentyl-DCBG) were prepared in 
DMSO. All stock solutions were stored at −20  °C until 
used. Test concentrations of compounds were prepared 
by diluting stock solution with 10  mM Tris–HCl pH 
8.0 and evaluated in triplicate. Compounds were added 
directly to the reaction mixtures except for NEM that was 
pre-incubated with enzyme for 30 min on ice before addi-
tion to the reaction mixture. Polymerase activity assays 
were conducted as described above.
Inhibition of intra‑erythrocytic P. falciparum growth 
in culture
Plasmodium falciparum K1 strain was synchronized at 
ring stage using 5 % D-sorbitol treatment and then mixed 
with culture medium containing RPMI 1640 medium 
supplement with 10  % human serum. Twofold serial 
dilutions of each test compound were evaluated in trip-
licate. Parasite growth was determined by a SYBR Green 
I-based assay [31, 32]. Dose–response curves and IC50 
values were obtained using SigmaPlot 12.0.
Results
Expression and purification of recombinant PfPolδ‑cat, 
PfPolδS and PfPCNA1
The 3285-bp full-length PfPolδ-cat of P. falciparum K1 
strain was successfully amplified and cloned employing 
pBAD202/D TOPO® expression vector. Its nucleotide 
sequence showed 99  % identity to that of P. falciparum 
3D7 (NCBI reference sequence XM_001347414.1). The 
deduced amino acid sequence (1094 amino acids) of 
PfPolδ-cat is 84 and 59.2 % similar to that of Plasmodium 
vivax and humans, respectively (Table 1).
Recombinant PfPolδ-cat was expressed as thioredoxin-
PfPolδ-cat-His6 fusion protein in Escherichia coli 
LMG194 and purified by Ni2+ affinity chromatography, 
having the expected size of 143 kDa. The method yielded 
0.48 mg of protein/l culture. Western blot analysis using 
His-specific antibody indicated a single PfPolδ-cat band 
of the expected 143 kDa (Fig. 1). After excision from gel, 
trypsin digestion and amino acid sequence analysis using 
LC–MS/MS, seven peptides were obtained that matched 
the sequence of P. falciparum 3D7 Polδ-cat with ion 
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scores of 100, indicating identity or extensive homology 
(p value < 0.05).
In addition to PfPolδ-cat, PfPolδS and PfPCNA1 were 
expressed and purified. PfPolδS was expressed under the 
regulation of T7 promoter and carried His6 at C-terminus. 
Affinity purified PfPolδS with a molecular mass of 57 kDa 
was obtained (Fig.  2), and its identity was confirmed by 
LC–MS/MS, which yielded five peptides matching P. fal-
ciparum 3D7 DNA polymerase δ small subunit with ion 
scores of 168. The deduce amino acid sequence of PfPolδS 
reveals 49.1 and 24.7 % similarity with that of P. vivax and 
human PolδS, respectively (Table  2). As PfPCNA1 has 
been characterized previously [27], the reported protocols 
were adapted to obtain a purified protein of 34 kDa with 
final yield of 4.35 mg/l culture (Fig. 3).
Biochemical characterization of PfPolδ‑cat
Recombinant PfPolδ-cat exhibited both DNA polymerase 
(Fig.  4) and 3′–5′ exonuclease activity, the latter prop-
erty being based on the release of [α-32P]dTMP from 
3′-labelled-poly(dA.dT), reducing TCA insoluble mate-
rial by 96.6  ±  1.2  % after 20  min incubation at 37  °C. 
PfPolδ-cat polymerase activity required presence of 
divalent metal ions, Mn2+ or Mg2+, with maximal poly-
merase activity being achieved at 2.5 and 5 mM respec-
tively (Fig. 4a). Although both divalent cations activated 
polymerase activity, PfPolδ-cat was approximately three-
fold more active in the presence of Mg2+ than Mn2+ at 
their respective optimal concentration. As regards KCl 
requirement, PfPolδ-cat showed maximal polymerase 
activity at 100 mM KCl and activity decreased when KCl 
was >200 mM (Fig. 4b).
Effects of PfPolδS and PfPCNA1 on PfPolδ‑cat polymerase 
activity
The effect of PfPolδS on PfPolδ-cat polymerase activ-
ity was determined by adding recombinant PfPolδS to a 
standard polymerase assay in the presence or absence of 
PfPCNA1. PfPolδS was able to stimulate PfPolδ-cat DNA 
polymerase activity threefold, which was abrogated in 
the presence of heat-treated PfPolδS (Fig.  5). However, 
the presence of PfPCNA1 alone did not alter PfPolδ-cat 
polymerase activity, but there was a fourfold increase in 
activity was when both PfPolδS and PfPCNA1 were pre-
sent (Fig. 6).
Table 1 Amino acid sequence similarity of PfPolδ-cat com-
pared with Polδ from other organisms
Organism Accession number 
of NCBI protein  
reference sequence
Similarity (%)
P. falciparum 3D7 XP_001347450.1 100
Plasmodium vivax Sal‑1 XP_001612703.1 84.0
Homo sapiens NP_001243778.1 59.2
Schizosaccharomyces pombe NP_596124.1 62.4
S. cerevisiae S288c NP_010181.2 59.4
Toxoplasma gondii XP_002365027.1 57.0
Mus musculus NP_035261.3 60.4
Fig. 1 SDS–PAGE and western blot analysis of PfPolδ‑cat expression. a SDS‑PAGE (7.5 %) and b western blot analysis of PfPolδ‑cat. Anti‑His antibody 
was used for western blot analysis. Lane M molecular weight markers; lane 1 induced whole cell of E. coli LMG194 carrying pBAD vector with lacZ 
gene containing His6 sequence; lane 2 non‑induced whole cell of E. coli LMG194 carrying pBAD vector; lane 3 non‑induced whole cell of E. coli 
LMG194 carrying PfPolδ‑cat vector; lane 4 induced whole cell of E. coli LMG194 carrying PfPolδ‑cat vector; lane 5 HisTrap HP column purified protein
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Processivity of PfPolδ‑cat
PfPolδ-cat processivity was investigated using (dA)1500.
(dT)12 as substrate in comparison with that of E. coli 
DNA polymerase Klenow fragment. In the presence of 
PfPolδS and PfPCNA1, PfPolδ-cat produced longer prod-
ucts (higher processivity) than in their absence (Fig. 7).
Effects of inhibitors on DNA polymerase activity 
of PfPolδ‑cat and parasite growth
Of the 11 synthetic compounds tested on PfPolδ polymer-
ase activity only four showed inhibitory effects, namely, 
BuPdGTP (IC50  =  38  µM), 7-acetoxypentyl-DCBG 
(IC50 = 55 µM), 2-amino-4-chloro-6-(3′,4′-dichloroanilino)
pyrimidine (IC50 =  104  µM) and 2-amino-4-chloro-6-(3′, 
5′-dichloroanilino)pyrimidine (IC50  =  185  µM), but still 
less potent than aphidicolin (IC50  =  11.8  μM) and NEM 
(IC50  =  8.6  mM), as seen with other eukaryotic Pol δ 
[14–16] (Table 3). These four compounds also inhibited P. 
falciparum K1 strain growth in culture, with IC50 values 
ranging from 3.8 to 85.6  µM (Table  3). However, DCBG, 
N2-(3-fluoro,4-chlorobenzyl)guanine and HB-EMAU 
exhibited inhibitory effects on P. falciparum growth, with 
IC50 values of 8.8, 7.4 and 10.2 μM, respectively.
Discussion
Since 1976, when, for the first time, Pol δ was described 
in bone marrow as a novel DNA polymerase possessing 
a 3′–5′ proofreading exonuclease activity [33], eukaryotic 
Polδs have been purified and characterized from several 
organisms [16, 17, 34], with the exception of malarial 
parasites.
PfPolδ partially purified from parasite crude extract 
using Hitrap Capto Q and Hitrap Heparin columns in 
a fast protein liquid chromatography (FPLC) system 
exhibited 3′–5′ exonuclease activity and was sensitive 
to aphidicolin and NEM (unpublished). However, possi-
ble co-purification of PfPolε could not be rule out. Sub-
sequent purification of PfPolδ to near homogeneity was 
hampered by very low recovery yield and a lack of Pol 
δ-specific affinity column able to separate it from PfPolε. 
Therefore, in this study a DNA recombinant approach 
was used to study PfPolδ catalytic subunit, in the pres-
ence of its small subunit PfPolδS and PfPCNA. Moreover, 
recombinant techniques provided sufficient amounts of 
enzyme to allow testing as a potential anti-malarial drug 
target.
Fig. 2 SDS–PAGE and western blot analysis of PfPolδS expression. a SDS–PAGE (10 %) and b western blot analysis of PfPolδS. Anti‑His antibody was 
used for western blot analysis. Lane M molecular weight markers; lane 1 positive control vector with lacZ gene containing His6 sequence; lane 2 non‑
induced whole cell of E. coli BL21 carrying pET vector; lane 3 non‑induced whole cell of E. coli BL21 carrying PfPolδS vector; lane 4 induced whole 
cell of E. coli BL21 carrying PfPolδS vector; lane 5 HisTrap HP column purified protein
Table 2 Amino acid sequence similarity of  PfPolδS com-
pared with other organisms
No. Organism GenBank  
accession no.
Similarity (%)
1 P. falciparum 3D7 CAB11105.1 85.9
2 P. vivax EDL43374.1 49.1
3 P. knowlesi strain H CAQ39738.1 51.4
4 H. sapiens AAC50216.1 24.7
5 S. pombe CAB11679.1 19.4
6 Entamoeba dispar EDR22929.1 16.9
7 Candida dubliniensis CD36 CAX41815.1 18.7
8 Culex quinquefasciatus EDS33455.1 24.0
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Recombinant PfPolδ was successfully cloned and heter-
ologously expressed in E. coli, but the expressed protein 
was produced in an insoluble form at 37 °C. The expres-
sion condition was optimized by reducing expression 
temperature, which usually increases soluble protein 
yield [35]. The size of expressed PfPolδ-cat was 126 kDa, 
comparable to 130 kDa of E. coli Pol III [36] and 125 kDa 
of purified human enzyme [16]. Tandem mass spectrom-
etry of trypsinized recombinant PfPolδ revealed seven 
peptides that showed high homology with the sequence 
of DNA polymerase δ catalytic subunit of P. falciparum 
strain 3D7. Characterization of recombinant PfPolδ-cat 
showed that it possesses both DNA polymerase activity 
and 3′–5′ exonuclease activity, as found in other mamma-
lian Polδs [16, 17, 34].
PCNA functions as a processivity factor for Pol δ by 
forming a molecular sliding clamp and also plays a crucial 
role in DNA transactions where it acts as a scaffold for 
the recruitment and organization of protein complexes 
involved in both DNA replication and repair [19]. A pre-
vious study of protein–protein interactions of human Pol 
δ-PCNA complex suggested that the interaction between 
Pol δ and PCNA likely happens through multiple con-
tacts via its four subunits, p12, p50, p68, and p125 [19, 
37]. In this study, PfPolδ-cat polymerase activity was 
stimulated threefolds with the addition of PfPolδS and 
fourfolds in the presence of both PfPolδS and PfPCNA. 
The magnitude of malarial enzyme activity stimulation 
is comparable to those obtained from examination of 
the effect of human recombinant p50 on the activity of 
DNA polymerase δ, showing that p50 is able to slightly 
stimulate (about twofold) the activity of the recombinant 
125 kDa catalytic subunit in the absence of PCNA, while 
in the presence of PCNA polymerase activity is stimu-
lated about fivefold [38]. In addition, a combination of 
PfPolδ-cat, PfPolδS and PfPCNA1 demonstrated high-
est processivity compared with individual protein or 
incomplete combination. These findings are consistent 
with previous report indicating that small subunit p50 is 
required for mediation of the interaction of human Pol 
δ catalytic subunit (p125) with PCNA [19]. In this study, 
replication factor C (RFC) or clamp loader of P. falcipa-
rum was not used in the assay with PfPolS and PCNA, 
and thus higher activity of PfPolδ-cat would be expected 
upon addition of RFC as the latter is responsible for load-
ing PCNA onto DNA during DNA replication [6]. In 
addition to its important function in DNA replication, a 
role of PfPolδ-cat in base excision repair should be inves-
tigated when additional enzymes or proteins in parasite 
BER pathway become available.
All DNA polymerases use the same two metal cations 
(usually Mg2+) as co-factors for dNTP polymerization. 
In this study, PfPolδ-cat was able to use both Mg2+ and 
Mn2+ and could be activated by 5  mM  Mg2+ as found 
for both human and calf thymus Pol δ [16, 17]. However, 
in the case of Mn2+, optimal concentration (2.5  mM) 
required by the parasite enzyme was five- to eightfold 
higher than that optimal for human and calf thymus Pol δ 
(0.3–0.5 mM) [39].
PfPolδ activity was differently affected by salt concentra-
tions compared with calf thymus and human recombinant 
enzymes. The maximal polymerase activity of PfPolδ-cat 
was at 100  mM KCl and declined at higher concentra-
tions (>200 mM). These findings are different from those 
Fig. 3 Analysis of recombinant PfPCNA1 expression by 12 % SDS–PAGE. Gel was stained with Coomassie blue R250. Lane M molecular weight 
markers; lane 1 non‑induced whole cells of E. coli JM109 expression host; lane 2 total soluble protein from 1 mM IPTG‑induced E. coli JM109 carrying 
PfPCNA1‑constructed vector; lanes 3–7 elution fractions from Ni–NTA agarose purified protein
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observed with recombinant human and calf thymus Pol 
δ, where only 50 and 38 % of enzyme activity respectively 
was found at 50 mM KCl [16, 39]. Unlike the human and 
calf thymus enzymes, Pol δ of Drosophila is slightly stim-
ulated by low KCl concentration (25 mM) [40]. Recombi-
nant Pol3 of Schizosaccharomyces pombe shows maximal 
activity at 240 mM KCl, whereas its native form is sensi-
tive to high salt concentration [41]. It is possible that KCl 
may help stabilize protein at a concentration suitable for 
function or to reduce its self-aggregation.
Only 4 of 11 synthetic compounds showed inhibitory 
effects on PfPolδ-cat activity when compared with known 
Fig. 4 Effects of divalent cation cofactors and KCl concentrations on 
PfPolδ‑cat. DNA polymerase activity of PfPolδ‑cat was determined 
using CT‑DNA as template‑primer. a PfPolδ‑cat activities were 
investigated in the presence of MgCl2 (circle) and MnCl2 (triangle) and 
presented as specific activity. b concentrations of KCl were varied as 
indicated. Maximal activity of enzyme is designated as 100 %. Data 
are shown as mean ± SD
Fig. 5 Stimulation of PfPolδ‑cat DNA polymerase activity. Assays 
were performed using poly(dA).oligo(dT) as template‑primer. The 
effects of PfPolδS (circle), PfPolδS in presence of 1 μM PCNA (square) 
were compared with 0.5 mg BSA (triangle) and heat‑treated PfPolδS 
(cross) as negative controls. Data are shown as mean ± SD
Fig. 6 Effects of recombinant PfPolδS and PfPCNA1 on PfPolδ‑cat 
activity. DNA polymerase activity was determined using poly(dA).
oligo(dT) as template‑primer. Activity of PfPolδ‑cat alone is presented 
as 100 % and data are shown as mean ± SD
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DNA polymerase inhibitors such as aphidicolin and NEM. 
The most potent inhibitor of PfPolδ-cat was BuPdGTP, 
which strongly inhibited mammalian Pol α compared 
with Pol δ and ε [42]. In contrast to BuPdGTP, 2-amino-
4-chloro-6-(3′,4′-dichloroanilino)pyrimidine showed low 
inhibitory effect on PfPolδ-cat but was the most potent 
inhibitor of parasite growth in culture. Inhibition of PfPolδ-
cat activity by these two compounds did not directly cor-
relate with parasite growth inhibition, suggesting that they 
may have different cell permeability and metabolic proper-
ties. However, 7-acetoxypentyl-DCBG was the most potent 
inhibitor of both PfPolδ-cat activity and parasite growth. 
Recently, 7-acetoxypentyl-DCBG was shown to be a potent 
antibiotic, showing an MIC of 1.25 μg/ml and a clear dose–
response effect (80 % mice survived after treatment with an 
IP dose of 60 mg/kg) [43]. Taken together, 7-acetoxypentyl-
DCBG is a promising starting template for future rational 
design of a selective inhibitor against PfPolδ and may lead 
to development of novel anti-malarial agents.
Conclusions
Recombinant PfPolδ-cat, PfPolδS and PfPCNA1 were suc-
cessfully expressed heterologously. PfPolδ-cat contains 
both DNA polymerase and 3′–5′ exonuclease activity as 
found in the human counterpart. However, recombinant 
PfPolδ-cat and PfPolδS differ from human enzymes in their 
deduced amino acid sequences. A combination of PfPolS 
and PfPCNA clearly stimulated PfPolδ-cat DNA polymer-
ase activity and processivity. Recombinant PfPolδ-cat was 
inhibited by two guanine analogs, namely, BuPdGTP and 
7-acetoxypentyl-DCBG. Furthermore, 7-acetoxypentyl-
DCBG was demonstrated to be a potent inhibitor of in vitro 
malaria parasite growth. Analogs of this compound should 
further be developed into more potent anti-malarial drugs.
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Fig. 7 Effects of PfPolδS and PfPCNA1 on processivity of PfPolδ‑cat. 
Lane 1 products of PfPolδ‑cat; lane 2 products of PfPolδ‑cat in the 
presence of PfPolδS; lane 3 PfPolδ‑cat in the presence of PfPolδS and 
PfPCNA1; lane 4 products of E.coli Klenow enzyme as positive control; 
lane 5 negative control
Table 3 Inhibitory effects (IC50) of  compounds on  PfPolδ-
cat activity and in vitro malaria parasite growth
a <20 % inhibition at 100 μM
Compound IC50 (µM)
PfPolδ‑cat P. falciparum
BuPdGTP 38.0 ± 1.7 85.6 ± 3.7
7‑acetoxypentyl‑DCBG 55.0 ± 3.4 4.1 ± 0.2
2‑amino‑4‑chloro‑6‑(3′,4′‑dichloroanilino)
pyrimidine
104.0 ± 5.6 3.8 ± 0.3
2‑amino‑4‑chloro‑6‑(3′, 5′‑dichloroanilino)
pyrimidine
185.0 ± 7.7 34.4 ± 0.4
BuPdGMPPCOP Inactivea 173.4 ± 2.7
EtdGTP Inactivea 157.8 ± 3.4
HexdGTP Inactivea 86.4 ± 0.2
Acyclovir triphosphate Inactivea 347.2 ± 8.3
DCBG Inactivea 8.8 ± 0.5
N2‑(3‑fluoro,4‑chlorobenzyl)guanine Inactivea 7.4 ± 0.3
HB‑EMAU Inactivea 10.2 ± 0.4
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